AU2003245981A1 - Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a) - Google Patents

Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)

Info

Publication number
AU2003245981A1
AU2003245981A1 AU2003245981A AU2003245981A AU2003245981A1 AU 2003245981 A1 AU2003245981 A1 AU 2003245981A1 AU 2003245981 A AU2003245981 A AU 2003245981A AU 2003245981 A AU2003245981 A AU 2003245981A AU 2003245981 A1 AU2003245981 A1 AU 2003245981A1
Authority
AU
Australia
Prior art keywords
therapeutics
diagnostics
receptor
diseases associated
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003245981A
Inventor
Ulf Bruggemeier
Andreas Geerts
Stefan Golz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2003245981A1 publication Critical patent/AU2003245981A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
AU2003245981A 2002-07-01 2003-06-24 Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a) Abandoned AU2003245981A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02014065 2002-07-01
EP02014065.3 2002-07-01
PCT/EP2003/006612 WO2004003567A1 (en) 2002-07-01 2003-06-24 Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)

Publications (1)

Publication Number Publication Date
AU2003245981A1 true AU2003245981A1 (en) 2004-01-19

Family

ID=29797137

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003245981A Abandoned AU2003245981A1 (en) 2002-07-01 2003-06-24 Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)

Country Status (2)

Country Link
AU (1) AU2003245981A1 (en)
WO (1) WO2004003567A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3299032A1 (en) 2016-09-23 2018-03-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Inhibitors of gpr132 for use in preventing and/or treating chemotherapy-induced neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207412B1 (en) * 1997-11-13 2001-03-27 The Regents Of The University Of California Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells
US6709830B2 (en) * 1997-11-13 2004-03-23 The Regents Of The University Of California Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation

Also Published As

Publication number Publication date
WO2004003567A1 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003289716A1 (en) Molecules for diagnostics and therapeutics
AU2003284123A1 (en) Composition and filter system using the said composition
AU2003285656A1 (en) System with macrocommands
AU2003251766A1 (en) Partially ester-exchanged sipm and process therewith
AU2003276220A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a)
AU2003301894A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d)
AU2003229735A1 (en) Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr)
AU2003215592A1 (en) Lightweight construction element and method for producing the same
AU2003210518A1 (en) Molecules for diagnostics and therapeutics
AU2002363338A1 (en) Diagnostics and therapeutics for ocular abnormalities
AU2003205627A1 (en) Diagnostics and therapeutics for diseases associated with gpr72
AU2003281698A1 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
AU2003276136A1 (en) Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1)
AU2003245981A1 (en) Diagnostics and therapeutics for diseases associated with the g2a-receptor (g2a)
AU2003229767A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003283427A1 (en) Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
AU2003283303A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003279361A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7B (PDE7b)
AU2003294728A1 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
AU2003274083A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a)
AU2003267380A1 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
AU2003216866A1 (en) Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
AU2003209224A1 (en) Batting system
AU2003218638A1 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase